Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from MicroPort CardioFlow Medtech Corp. ( (HK:2160) ).
MicroPort CardioFlow Medtech Corporation has revised the expected timetable for its proposed share consolidation, citing additional time needed for logistical arrangements related to trading operations. The new schedule confirms key dates for shareholder eligibility to attend and vote at the extraordinary general meeting in early February 2026, while maintaining the planned effective date of the consolidation and commencement of trading in consolidated shares on 24 February 2026, signalling continued commitment to the capital restructuring despite operational delays.
The most recent analyst rating on (HK:2160) stock is a Hold with a HK$0.87 price target. To see the full list of analyst forecasts on MicroPort CardioFlow Medtech Corp. stock, see the HK:2160 Stock Forecast page.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corporation is a Hong Kong-listed medical technology company focused on cardiovascular intervention solutions. It develops and markets devices and systems used in cardiac procedures, targeting both domestic and international healthcare markets with an emphasis on minimally invasive cardiovascular therapies.
Average Trading Volume: 5,907,041
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.54B
For detailed information about 2160 stock, go to TipRanks’ Stock Analysis page.